SHISX Mutual Fund

NAV$61.95

Fund Essentials - as of Aug 29, 2025

Net Assets
$23M
Expense Ratio
1.15%
Dividend Yield (Current)
10.28%
Holdings
139
Inception Date
Jan 28, 2005
Fund Family
BlackRock, Inc. (US)
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+2.27%
1 Year+10.53%
3 Year+10.43%
5 Year+6.43%
10 Year+11.21%

Asset Allocation

Stocks: 98.80%
Cash: 1.10%
Other: 0.10%

Top Holdings

View All →
TickerNameWeight
JNJJohnson & Johnson7.82%
LLYEli Lilly & Co7.46%
ABTAbbott Laboratories5.90%
BSXBoston Scientific Corp4.66%
ABBVAbbvie Inc4.29%
Top 10 Concentration: 47.54%Report Date: Aug 29, 2025
Download all 139 holdings for SHISX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.28%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

SHISX Mutual Fund Overview

SHISX Mutual Fund (BlackRock Health Sciences Opportunity Service Class) is managed by BlackRock, Inc. (US) with $22.7M in net assets. SHISX expense ratio is 1.15%, holding 139 positions across sectors including Health Care, Unknown, Financials. Inception date: 2005-01-28.

SHISX performance shows a YTD return of 2.27%. The 1-year return is 10.53% and the 5-year return is 6.43%. SHISX dividend yield stands at 10.28%, paid annually.

SHISX top holdings include Johnson & Johnson (7.8%), Eli Lilly & Co (7.5%), Abbott Laboratories (5.9%), Boston Scientific Corp (4.7%), Abbvie Inc (4.3%). View all SHISX holdings, sector breakdown, or dividend history.

SHISX can be compared against other funds using the overlap calculator or side-by-side comparison tool. SHISX alternatives are available via the screener, along with tax-loss harvesting opportunities.